利妥昔单抗治疗难治性亚急性皮肤型红斑狼疮 - Suppr

Suppr

超能文献

[Refractory subacute cutaneous lupus erythematosus treated with rituximab].

作者信息

Cieza-Díaz D E, Avilés-Izquierdo J A, Ceballos-Rodríguez C, Suárez-Fernández R

出版信息

Actas Dermosifiliogr. 2012 Jul-Aug;103(6):555-7. doi: 10.1016/j.ad.2011.10.013. Epub 2012 Apr 5.

DOI:10.1016/j.ad.2011.10.013

PMID:22482740

Abstract

摘要

相似文献

[Refractory subacute cutaneous lupus erythematosus treated with rituximab].利妥昔单抗治疗难治性亚急性皮肤型红斑狼疮

Actas Dermosifiliogr. 2012 Jul-Aug;103(6):555-7. doi: 10.1016/j.ad.2011.10.013. Epub 2012 Apr 5.

Remission of incapacitating acute cutaneous lupus erythematosus in a patient with systemic lupus erythematosus by B cell-depletive therapy.采用B细胞清除疗法使一名系统性红斑狼疮患者的致残性急性皮肤型红斑狼疮得到缓解。

J Clin Rheumatol. 2010 Oct;16(7):345. doi: 10.1097/RHU.0b013e3181f4e4b7.

Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.米帕林与羟氯喹联合治疗系统性红斑狼疮伴难治性皮肤和关节活动患者。

Lupus. 2018 Sep;27(10):1718-1722. doi: 10.1177/0961203318768877. Epub 2018 Apr 10.

Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus successfully treated with a single dose of etanercept: report of three cases.单剂量依那西普成功治疗中毒性表皮坏死松解症样急性皮肤型红斑狼疮：三例报告

J Am Acad Dermatol. 2013 Dec;69(6):e303-5. doi: 10.1016/j.jaad.2013.07.036.

[Thalidomide therapy of cutaneous lupus erythematosus].[沙利度胺治疗皮肤红斑狼疮]

Hautarzt. 2002 Nov;53(11):744-8. doi: 10.1007/s001050100227.

Etanercept for the treatment of intractable hemophagocytic syndrome with systemic lupus erythematosus.依那西普治疗系统性红斑狼疮伴发难治性噬血细胞综合征。

Mod Rheumatol. 2012 Apr;22(2):308-11. doi: 10.1007/s10165-011-0500-1. Epub 2011 Jul 20.

Cutaneous lupus erythematosus: update of therapeutic options part II.皮肤红斑狼疮：治疗选择的更新 Ⅱ 部分。

J Am Acad Dermatol. 2011 Dec;65(6):e195-213. doi: 10.1016/j.jaad.2010.06.017. Epub 2010 Aug 30.

Long-term efficacy and safety of rituximab in refractory and relapsing systemic lupus erythematosus.利妥昔单抗治疗难治性和复发性系统性红斑狼疮的长期疗效和安全性。

Nephrol Dial Transplant. 2010 Nov;25(11):3586-92. doi: 10.1093/ndt/gfq256. Epub 2010 May 11.

[Recurrent diffuse alveolar hemorrhage in systemic lupus erytematosus treated with rituximab and immunoglobulins].利妥昔单抗和免疫球蛋白治疗系统性红斑狼疮复发性弥漫性肺泡出血

Med Clin (Barc). 2015 Dec 7;145(11):507-8. doi: 10.1016/j.medcli.2015.02.007. Epub 2015 Apr 7.

Case reports of etanercept in inflammatory dermatoses.依那西普治疗炎症性皮肤病的病例报告。

J Am Acad Dermatol. 2006 Mar;54(3 Suppl 2):S139-42. doi: 10.1016/j.jaad.2005.11.1090.

引用本文的文献

B cell depletion therapy using rituximab to induce long-term remission of recalcitrant skin lesions of subacute cutaneous lupus erythematosus.采用利妥昔单抗进行 B 细胞耗竭疗法诱导亚急性皮肤型红斑狼疮顽固皮损的长期缓解。

BMJ Case Rep. 2022 May 27;15(5):e248476. doi: 10.1136/bcr-2021-248476.

Rituximab in the treatment of extensive and refractory subacute cutaneous lupus erythematosus.利妥昔单抗治疗广泛性难治性亚急性皮肤型红斑狼疮

An Bras Dermatol. 2018 Jun;93(3):467-469. doi: 10.1590/abd1806-4841.20187561.

Intravenous immunoglobulins for treatment of connective tissue diseases in dermatology.静脉注射免疫球蛋白在皮肤科结缔组织疾病治疗中的应用

Wien Med Wochenschr. 2018 Jun;168(9-10):213-217. doi: 10.1007/s10354-017-0595-x. Epub 2017 Sep 1.

Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects.治疗皮肤红斑狼疮的选择：最新进展和未来前景。

Expert Rev Clin Immunol. 2016 Oct;12(10):1109-21. doi: 10.1080/1744666X.2016.1188006. Epub 2016 Jun 1.

Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus--report of 17 cases and review of the literature.利妥昔单抗为基础的 B 细胞耗竭疗法对红斑狼疮皮肤表现的影响——17 例报告及文献复习。

Lupus. 2013 Aug;22(9):932-9. doi: 10.1177/0961203313497115.

Treatment of Cutaneous Lupus Erythematosus: Review and Assessment of Treatment Benefits Based on Oxford Centre for Evidence-based Medicine Criteria.皮肤红斑狼疮的治疗：基于牛津循证医学中心标准对治疗益处的综述与评估

J Clin Aesthet Dermatol. 2013 Jan;6(1):27-38.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验